A combination of IL-1β and IL-8 at the optimal cut-points excluded VAP with a sensitivity of 100% and specificity of 44.3% and was proposed as a rapid biomarker-based rule-out test with the potential to improve antibiotic stewardship [10]. The gene discussed is IL1B; the disease is ventilator-associated pneumonia.